BRAINSTORM CELL THERAPEUTICS LTD has a total of 28 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2013. It filed its patents most often in Canada, EPO (European Patent Office) and Israel. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are NEUROGENEX CO LTD, ONCOLYS BIOPHARMA INC and STEMBIOS TECHNOLOGIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Israel | 4 | |
#4 | United States | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | Australia | 2 | |
#7 | Hong Kong | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Brazil | 1 | |
#10 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Analysing materials | |
#5 | Peptides | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Gothelf Yael | 23 |
#2 | Aricha Revital | 13 |
#3 | Kaspi Haggai | 13 |
#4 | Levy Yosef | 10 |
#5 | Semo Jonathan | 7 |
#6 | Abramov Natalie | 6 |
#7 | Burshtein Alex | 6 |
#8 | Yael Gothelf | 5 |
#9 | Yosef Levy | 5 |
#10 | Alex Burshtein | 3 |
Publication | Filing date | Title |
---|---|---|
KR20200142045A | Cell type-specific exosomes and their uses | |
AU2017301035A1 | Methods for treating amyotrophic lateral sclerosis (ALS) | |
CA2937305A1 | Pharmaceutical composition comprising bone-marrow derived mesenchymal stem cells | |
EP2880151A1 | Methods of generating mesenchymal stem cells which secrete neurotrophic factors |